Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004
Published online before print July 22, 2004, doi: 10.1161/01.RES.0000139957.22530.b9
A more recent version of this article appeared on September 3, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/5/532    most recent
01.RES.0000139957.22530.b9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmerman, M. C.
Right arrow Articles by Davisson, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmerman, M. C.
Right arrow Articles by Davisson, R. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Functional genomics
Right arrow Genetically altered mice
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Oxidant stress

Submitted on April 12, 2004
Revised on July 8, 2004
Accepted on July 12, 2004

Requirement for Rac1-Dependent NADPH Oxidase in the Cardiovascular and Dipsogenic Actions of Angiotensin II in the Brain

Matthew C. Zimmerman ; Ryan P. Dunlay ; Eric Lazartigues ; Yulong Zhang ; Ram V. Sharma ; John F. Engelhardt ; and Robin L. Davisson *

From the Department of Anatomy and Cell Biology (M.C.Z., R.P.D., E.L., Y.Z., R.V.S., J.F.E., R.L.D.), the Free Radical and Radiation Biology Program, the Department of Radiation Oncology (M.C.Z., R.L.D.), the Center for Gene Therapy of Cystic Fibrosis and Other Genetic Diseases (Y.Z., J.F.E., R.L.D.), The Cardiovascular Center (R.V.S., R.L.D.), The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City.

* To whom correspondence should be addressed. E-mail: robin-davisson{at}uiowa.edu.

We have shown that intracellular superoxide (O2·-) production in CNS neurons plays a key role in the pressor, bradycardic, and dipsogenic actions of Ang II in the brain. In this study, we tested the hypothesis that a Rac1-dependent NADPH oxidase is a key source of O2·- in Ang II-sensitive neurons and is involved in these central Ang II-dependent effects. We performed both in vitro and in vivo studies using adenoviral (Ad)-mediated expression of dominant-negative Rac1 (AdN17Rac1) to inhibit Ang II-stimulated Rac1 activation, an obligatory step in NADPH oxidase activation. Ang II induced a time-dependent increase in Rac1 activation and O2·- production in Neuro-2A cells, and this was abolished by pretreatment with AdN17Rac1 or the NADPH oxidase inhibitors apocynin or diphenylene iodonium. AdN17Rac1 also inhibited Ang II-induced increases in NADPH oxidase activity in primary neurons cultured from central cardiovascular control regions. In contrast, overexpression of wild-type Rac1 (AdwtRac1) caused more robust NADPH oxidase-dependent O2·- production to Ang II. To extend the in vitro studies, the pressor, bradycardic, and drinking responses to intracerebroventricularly (ICV) injected Ang II were measured in mice that had undergone gene transfer of AdN17Rac1 or AdwtRac1 to the brain. AdN17Rac1 abolished the increase in blood pressure, decrease in heart rate, and drinking response induced by ICV injection of Ang II, whereas AdwtRac1 enhanced these physiological effects. The exaggerated physiological responses in AdwtRac1-treated mice were abolished by O2·- scavenging. These results, for the first time, identify a Rac1-dependent NADPH oxidase as the source of central Ang II-induced O2·- production, and implicate this oxidase in cardiovascular diseases associated with dysregulation of brain Ang II signaling, including hypertension.


Key words: reactive oxygen species • dominant-negative Rac1 • blood pressure • dipsogenic response • neurons




This article has been cited by other articles:


Home page
HypertensionHome page
J. R. Peterson, M. A. Burmeister, X. Tian, Y. Zhou, M. R. Guruju, J. A. Stupinski, R. V. Sharma, and R. L. Davisson
Genetic Silencing of Nox2 and Nox4 Reveals Differential Roles of These NADPH Oxidase Homologues in the Vasopressor and Dipsogenic Effects of Brain Angiotensin II
Hypertension, November 1, 2009; 54(5): 1106 - 1114.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Capone, J. Anrather, T. A. Milner, and C. Iadecola
Estrous Cycle-Dependent Neurovascular Dysfunction Induced by Angiotensin II in the Mouse Neocortex
Hypertension, August 1, 2009; 54(2): 302 - 307.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. E. Lindley, D. W. Infanger, M. Rishniw, Y. Zhou, M. F. Doobay, R. V. Sharma, and R. L. Davisson
Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R1 - R8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Xue, Y. Zhao, A. K. Johnson, and M. Hay
Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1025 - H1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belmadani, M. Zerfaoui, H. A. Boulares, D. I. Palen, and K. Matrougui
Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, {alpha}v{beta}3-integrin, and TGF-{beta}1 in response to ANG II and high glucose
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H69 - H76.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. S. Hoffmann, C. J. Weydert, E. Lazartigues, W. J. Kutschke, M. F. Kienzle, J. E. Leach, J. A. Sharma, R. V. Sharma, and R. L. Davisson
Chronic Tempol Prevents Hypertension, Proteinuria, and Poor Feto-Placental Outcomes in BPH/5 Mouse Model of Preeclampsia
Hypertension, April 1, 2008; 51(4): 1058 - 1065.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. J. Guzik, N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
J. Exp. Med., October 1, 2007; 204(10): 2449 - 2460.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Cao, X. Dai, L. M. Parker, and D. L. Kreulen
Differential Regulation of NADPH Oxidase in Sympathetic and Sensory Ganglia in Deoxycorticosterone Acetate Salt Hypertension
Hypertension, October 1, 2007; 50(4): 663 - 671.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Nozoe, Y. Hirooka, Y. Koga, Y. Sagara, T. Kishi, J. F. Engelhardt, and K. Sunagawa
Inhibition of Rac1-Derived Reactive Oxygen Species in Nucleus Tractus Solitarius Decreases Blood Pressure and Heart Rate in Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, July 1, 2007; 50(1): 62 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Q. Chen and H.-L. Pan
Signaling Mechanisms of Angiotensin II-Induced Attenuation of GABAergic Input to Hypothalamic Presympathetic Neurons
J Neurophysiol, May 1, 2007; 97(5): 3279 - 3287.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y.-X. Pan, L. Gao, W.-Z. Wang, H. Zheng, D. Liu, K. P. Patel, I. H. Zucker, and W. Wang
Exercise Training Prevents Arterial Baroreflex Dysfunction in Rats Treated With Central Angiotensin II
Hypertension, March 1, 2007; 49(3): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Sinnayah, E. Lazartigues, K. Sakai, R. V. Sharma, C. D. Sigmund, and R. L. Davisson
Genetic Ablation of Angiotensinogen in the Subfornical Organ of the Brain Prevents the Central Angiotensinergic Pressor Response
Circ. Res., November 10, 2006; 99(10): 1125 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. D. Hingtgen, X. Tian, J. Yang, S. M. Dunlay, A. S. Peek, Y. Wu, R. V. Sharma, J. F. Engelhardt, and R. L. Davisson
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy
Physiol Genomics, September 14, 2006; 26(3): 180 - 191.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. M. Paravicini and R. M. Touyz
Redox signaling in hypertension
Cardiovasc Res, July 15, 2006; 71(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Zhou, C. Ziegler, L. A. Birder, A. F.R. Stewart, and E. S. Levitan
Angiotensin II and Stretch Activate NADPH Oxidase to Destabilize Cardiac Kv4.3 Channel mRNA
Circ. Res., April 28, 2006; 98(8): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Dodic, A. T. McAlinden, A. J. Jefferies, E. M. Wintour, M. L. Cock, C. N. May, R. G. Evans, and K. M. Moritz
Differential effects of prenatal exposure to dexamethasone or cortisol on circulatory control mechanisms mediated by angiotensin II in the central nervous system of adult sheep
J. Physiol., March 15, 2006; 571(3): 651 - 660.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Sherrod, D. R. Davis, X. Zhou, M. D. Cassell, and C. D. Sigmund
Glial-specific ablation of angiotensinogen lowers arterial pressure in renin and angiotensinogen transgenic mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1763 - R1769.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. H. Zucker and L. Gao
The Regulation of Sympathetic Nerve Activity by Angiotensin II Involves Reactive Oxygen Species and MAPK
Circ. Res., October 14, 2005; 97(8): 737 - 739.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. H.H. Chan, K.-S. Hsu, C.-C. Huang, L.-L. Wang, C.-C. Ou, and J. Y.H. Chan
NADPH Oxidase-Derived Superoxide Anion Mediates Angiotensin II-Induced Pressor Effect via Activation of p38 Mitogen-Activated Protein Kinase in the Rostral Ventrolateral Medulla
Circ. Res., October 14, 2005; 97(8): 772 - 780.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Gao, W. Wang, Y.-L. Li, H. D. Schultz, D. Liu, K. G. Cornish, and I. H. Zucker
Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart Failure: Roles of Angiotensin II Type 1 Receptors and NAD(P)H Oxidase
Circulation, September 20, 2005; 112(12): 1763 - 1770.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Sun, K. W. Sellers, C. Sumners, and M. K. Raizada
NAD(P)H Oxidase Inhibition Attenuates Neuronal Chronotropic Actions of Angiotensin II
Circ. Res., April 1, 2005; 96(6): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. Zimmerman, R. V. Sharma, and R. L. Davisson
Superoxide Mediates Angiotensin II-Induced Influx of Extracellular Calcium in Neural Cells
Hypertension, April 1, 2005; 45(4): 717 - 723.
[Abstract] [Full Text] [PDF]